Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hibma

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Journal of Virology|September 13, 2003
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markersKate Middleton, Woei Peh, Shirley Southern, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 8, 2019
Acceptability of self-taken vaginal HPV sample for cervical screening among an under-screened Indigenous populationAnna Adcock, Fiona Cram, Beverley Lawton, et al.
Clinical Pharmacology and Therapeutics|August 12, 2015
Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for childrenR M Savic, R Ruslami, J E Hibma, et al.
Clinical Pharmacokinetics|June 13, 2026
Elranatamab Population Pharmacokinetics and Exposure-Response for Cytokine Release Syndrome in Patients with Relapsed or Refractory Multiple MyelomaJennifer E Hibma, Donald Irby, Alan Liu, et al.
Journal of Lower Genital Tract Disease|August 3, 2016
Observational Management of CIN 2 in Young Women: A Prospective Multicenter TrialPeter Sykes, Carrie Innes, Dianne Harker, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Plos One|March 23, 2023
Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trialMelanie Gibson-Helm, Tania Slater, Evelyn J MacDonald, et al.
The Lancet. Oncology|August 10, 2019
Cancer management in the Pacific region: a report on innovation and good practiceAlec Ekeroma, Rachel Dyer, Neal Palafox, et al.
Papillomavirus Research (Amsterdam, Netherlands)|November 5, 2018
Changes in human papillomavirus genotypes associated with cervical intraepithelial neoplasia grade 2 lesions in a cohort of young women (2013-2016)Carrie R Innes, Peter H Sykes, Dianne Harker, et al.
Journal of Primary Health Care|January 21, 2026
'Point-of-Care-Testing is definitely the way to go': primary healthcare professionals in rural Aotearoa New Zealand talk about point-of-care testing for cervical cancer preventionNgaire Kereru Sparkes, Anna Adcock, Tania Slater, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Journal of Virology|September 13, 2003
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markersKate Middleton, Woei Peh, Shirley Southern, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 8, 2019
Acceptability of self-taken vaginal HPV sample for cervical screening among an under-screened Indigenous populationAnna Adcock, Fiona Cram, Beverley Lawton, et al.
Clinical Pharmacology and Therapeutics|August 12, 2015
Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for childrenR M Savic, R Ruslami, J E Hibma, et al.
Clinical Pharmacokinetics|June 13, 2026
Elranatamab Population Pharmacokinetics and Exposure-Response for Cytokine Release Syndrome in Patients with Relapsed or Refractory Multiple MyelomaJennifer E Hibma, Donald Irby, Alan Liu, et al.
Journal of Lower Genital Tract Disease|August 3, 2016
Observational Management of CIN 2 in Young Women: A Prospective Multicenter TrialPeter Sykes, Carrie Innes, Dianne Harker, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Plos One|March 23, 2023
Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trialMelanie Gibson-Helm, Tania Slater, Evelyn J MacDonald, et al.
The Lancet. Oncology|August 10, 2019
Cancer management in the Pacific region: a report on innovation and good practiceAlec Ekeroma, Rachel Dyer, Neal Palafox, et al.
Papillomavirus Research (Amsterdam, Netherlands)|November 5, 2018
Changes in human papillomavirus genotypes associated with cervical intraepithelial neoplasia grade 2 lesions in a cohort of young women (2013-2016)Carrie R Innes, Peter H Sykes, Dianne Harker, et al.
Journal of Primary Health Care|January 21, 2026
'Point-of-Care-Testing is definitely the way to go': primary healthcare professionals in rural Aotearoa New Zealand talk about point-of-care testing for cervical cancer preventionNgaire Kereru Sparkes, Anna Adcock, Tania Slater, et al.
Pageof 12